Research / ACCS / Fundamental state Inspectable configuration
State dimensions Filing 0001654954-24-002824 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
59.66% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.07% · OPTIONAL · VALID
Operating cash generation 15th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.17% · OPTIONAL · VALID
Revenue growth 85th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
41.95% · CORE · VALID
Gross margin 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
76.24% · CORE · VALID
Operating margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
8.44% · CORE · VALID
R&D intensity 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7.64% · OPTIONAL · VALID
SBC intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.09% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 70 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/8 normalized Level 3 Jun 30, 2024 7/8 normalized Level 3 Sep 30, 2024 7/8 normalized Level 3 Dec 31, 2024 6/7 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 263.02%
Current 59.66%
Delta -203.36% Capex Intensity Decreased
Previous 0.20%
Current 0.07%
Delta -0.12% Cash Generation Increased
Previous 3.79%
Current 9.17%
Delta 5.38% Growth Decreased
Previous 43.35%
Current 41.95%
Delta -1.40% Margin Decreased
Previous 76.26%
Current 76.24%
Delta -0.01% Profitability Increased
Previous 7.83%
Current 8.44%
Delta 0.60% R And D Intensity Decreased
Previous 7.68%
Current 7.64%
Delta -0.03% Sbc Intensity Decreased
Previous 4.74%
Current 4.09%
Delta -0.65% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.